Palvella Therapeutics (NasdaqCM:PVLA) Update / Briefing September 24, 2025 08:30 AM ET Company ParticipantsBohan Wei - VP - Corporate Development & New Product PlanningWes Kaupinen - President, CEO & DirectorJames Treat - Associate Professor - Clinical Pediatrics & DermatologyJeff Martini - Chief Scientific OfficerMatthew Korenberg - CFOOperatorGood day, and thank you for standing by. Welcome to the Palvella Therapeutics conference call to discuss expansion of QTORIN™ rapamycin 3.9% anhydrous gel pipeline t ...